Hexagon Nutrition Limited has closed its trading window for all insiders effective June 12, 2026, to prevent potential insider trading ahead of its quarterly financial results. The window will remain shut until 48 hours after the company declares its financial results for the quarter ended June 30, 2026. This measure is intended to ensure compliance with regulatory standards and maintain fair disclosure practices.

The closure applies to all directors, officers, designated persons, and their immediate relatives. The decision aligns with the company's Code of Conduct for Regulating, Monitoring, and Reporting of Trading by Insiders and its Code of Practices and Procedures for Fair Disclosure. These protocols are enforced pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time.

Hexagon Nutrition has informed all designated persons about the trading restrictions. The company is yet to announce the specific date for its board meeting to approve the financial results for the quarter ended June 30, 2026, and the financial year ending March 31, 2027. This information will be communicated in accordance with the timelines prescribed under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key Details

The filing was submitted by Vedanti Swapnil Vartak, Company Secretary and Compliance Officer of Hexagon Nutrition Limited.

Hexagon Nutrition made its stock market debut on the BSE, listing at ₹48 per share — a premium over its issue price of ₹45 per share. The listing marks the company's entry into the public markets, with shares opening above the offer price on the first day of trading.

Listing Performance at a Glance

The following table summarizes the key listing details for Hexagon Nutrition on the BSE:

The stock opened at ₹48 on the BSE, translating to a listing gain of ₹3 over the issue price of ₹45 per share. This debut reflects investor interest in the company at the time of its market entry.